Our observation of increased responses to DOX treatment in the presence of IFN-β is consistent with previous studies that IFN-β production during virally induced ICD increases responses to DOX,10 supporting this mechanistic link following virus infection. The gene discussed is IFNB1; the disease is viral infectious disease.